Two Categories of CRSDs

Intrinsic (Endogenous) Disorders:

• The internal clock itself is altered
• Period runs too fast or too slow
• Examples: Delayed Sleep Phase Disorder, Advanced Sleep Phase Disorder, Non-24 Hour Disorder
• Often have genetic component

Extrinsic (Environmental) Disorders:

• Normal internal clock, but misaligned with environment
• External demands conflict with natural rhythm
• Examples: Shift Work Disorder, Jet Lag Disorder
• Caused by behavioral or environmental factors

Common Symptoms Across All Types

When Trying to Sleep at "Wrong" Time:

• Severe insomnia
• Long sleep latency (trouble falling asleep)
• Difficulty staying asleep
• Non-restorative sleep

When Trying to be Awake at "Wrong" Time:

• Excessive daytime sleepiness
• Difficulty concentrating
• Impaired performance
• Accidents and errors
• Mood disturbances

Key Distinguishing Feature:

• Sleep is normal when allowed to occur at the person's natural preferred time
• Sleep architecture and quality are typically intact
• Problem is timing mismatch, not sleep ability

Impact on Life

Academic/Work Performance:

• Difficulty meeting schedule demands
• Chronic tardiness or absenteeism
• Reduced productivity and attention
• Increased errors and accidents

Health Consequences:

• Increased risk of depression and anxiety
• Metabolic disorders (diabetes, obesity)
• Cardiovascular disease
• Weakened immune function
• Increased cancer risk (shift work)

Social/Relationship:

• Difficulty maintaining social commitments
• Relationship strain
• Social isolation
• Reduced quality of life

The Suprachiasmatic Nucleus (SCN)

Master Pacemaker:

• Located in anterior hypothalamus, above optic chiasm
• Contains approximately 20,000 neurons
• Generates self-sustained 24-hour rhythm
• Coordinates all body clocks (heart, liver, kidneys, etc.)
• Functions without external cues, but normally entrained by them

Clock Gene Mechanism:

• Circadian rhythms generated at molecular level
• Clock proteins oscillate via autoregulatory feedback loops
• CLOCK, BMAL1, PER, CRY genes create timing system
• Approximately 24-hour period maintained automatically
• Present in every cell, but SCN orchestrates coordination

Light: The Primary Zeitgeber

How Light Entrains the Clock:

• Detection: Specialized retinal ganglion cells (intrinsically photosensitive)
• Photopigment: Melanopsin (most sensitive to blue light ~460-480nm)
• Pathway: Retinohypothalamic tract directly to SCN
• Response: SCN adjusts clock to match light-dark cycle
• Melatonin Suppression: Light inhibits pineal melatonin release

Light Phase Response Curve (PRC):

• Evening Light (before CBT minimum): Delays circadian phase (shifts later)
• Morning Light (after CBT minimum): Advances circadian phase (shifts earlier)
• Core Body Temperature (CBT) minimum: Occurs ~2 hours before natural wake time
• Maximum advance: Light 1-2 hours after CBT minimum
• Maximum delay: Light 2-3 hours before CBT minimum

Melatonin: The Darkness Signal

Melatonin's Role:

• Hormone secreted by pineal gland
• Signals nighttime/darkness to brain and body
• Release controlled by SCN
• Suppressed by bright light exposure
• Peaks during middle of night

Natural Pattern:

• Begins rising ~2 hours before habitual bedtime
• Dim Light Melatonin Onset (DLMO): Reliable phase marker
• Remains elevated throughout sleep period
• Decreases in morning with light exposure

Melatonin Phase Response Curve:

• Approximately 12 hours opposite to light PRC
• Evening dose (5-7 hours before sleep): Advances phase (shifts earlier)
• Morning dose (after wake): Delays phase (shifts later)
• Maximum advance: 3-5 hours before DLMO
• Lower doses (0.3-0.5mg) may be more effective than high doses

1. Delayed Sleep-Wake Phase Disorder (DSWPD)

MOST COMMON CIRCADIAN DISORDER

Description:

• Sleep-wake cycle delayed 2-6+ hours later than desired
• Cannot fall asleep until very late (2-6 AM typical)
• Extreme difficulty waking at conventional times
• Sleep is normal once it occurs
• Chronic when left untreated

Demographics:

• Affects 7-16% of adolescents and young adults
• Peak onset: Puberty through mid-20s
• More common in males
• Often persists into adulthood if untreated
• Strong genetic component (family history common)

Typical Pattern:

• Natural sleep time: 2-6 AM
• Natural wake time: 10 AM - 2 PM
• If allowed to sleep on natural schedule: sleep is normal duration and quality
• When forced to conventional schedule: severe sleep deprivation

Consequences:

• Chronic sleep deprivation (if forced to wake early)
• School/work tardiness, absenteeism
• Academic underachievement
• Labeled as "lazy" or unmotivated
• Depression, anxiety (secondary)
• Social isolation
• Often misdiagnosed as insomnia or depression

Diagnosis:

• Sleep diary showing consistent late sleep-wake pattern
• Actigraphy (wrist monitor) for 7-14 days
• Dim Light Melatonin Onset (DLMO) measurement
• Rule out behavioral causes (poor sleep hygiene)

2. Advanced Sleep-Wake Phase Disorder (ASWPD)

Description:

• Sleep-wake cycle advanced 2-4+ hours earlier than desired
• Extreme sleepiness in early evening (6-9 PM)
• Awakening very early morning (2-5 AM)
• Cannot stay awake for evening social activities
• Cannot sleep in or return to sleep after early wake

Demographics:

• More common in older adults (especially >60)
• Affects ~1% of middle-aged adults
• Familial form exists (rare genetic mutation in PER2 gene)
• Equal gender distribution

Typical Pattern:

• Natural sleep time: 6-9 PM
• Natural wake time: 2-5 AM
• Total sleep time often normal
• Sleep quality normal when on natural schedule

Consequences:

• Inability to attend evening social events
• Relationship difficulties
• Social isolation
• Often less distressing than DSWPD (compatible with work)
• May be misdiagnosed as depression

vs. "Morning Lark" Chronotype:

• ASWPD: Extreme, causes significant impairment
• Morning chronotype: Natural preference, functions well
• ASWPD: Cannot stay awake for normal evening activities

3. Shift Work Disorder (SWD)

Description:

• Insomnia during desired sleep time and/or excessive sleepiness during work
• Caused by work schedule conflicting with circadian rhythm
• Most common with night shifts or rotating shifts
• Symptoms must persist for 3+ months
• Occurs in 10-38% of shift workers

Shift Work Statistics:

• Affects 1 in 5 workers in industrialized world
• Healthcare, emergency services, manufacturing, transportation
• Permanent night workers adapt better than rotating shifts
• Not all shift workers develop SWD (10-38% do)

Sleep Problems:

• Daytime sleep 1-4 hours shorter than nighttime sleep
• Lighter, more fragmented sleep during day
• Difficulty falling asleep (light, noise, family)
• Chronic sleep debt accumulates
• Weekend recovery often insufficient

Performance/Safety Consequences:

• Severe sleepiness during night work (especially 3-7 AM)
• 18% increase in errors/accidents
• Microsleeps, attention lapses
• Motor vehicle accidents (commute home especially dangerous)
• Major industrial accidents often occur during night shifts

Health Consequences:

• Increased risk cardiovascular disease (40%)
• Metabolic syndrome, diabetes, obesity
• Breast cancer (WHO classified night work as probable carcinogen)
• Gastrointestinal disorders
• Depression, mood disorders
• Substance use (caffeine, alcohol, sleeping pills)

Shift Rotation Directions:

• Clockwise (easier): Day → Evening → Night (follows natural tendency to delay)
• Counter-clockwise (harder): Night → Evening → Day (fights natural rhythm)
• Slower rotation better: Weekly or longer allows partial adaptation
• Rapid rotation worse: Never allows adaptation

4. Non-24-Hour Sleep-Wake Disorder (Non-24 / Free-Running)

Description:

• Circadian rhythm not entrained to 24-hour day
• Sleep-wake cycle drifts progressively later (or occasionally earlier)
• Period typically 24.5-25 hours (but can vary)
• Sleep time shifts 1-2 hours later each day
• Cycles through alignment and misalignment with environment

In Totally Blind Individuals:

• Prevalence: 55-70% of totally blind people
• Cause: Lack of light perception → SCN cannot entrain
• Most common: Damage to retinal ganglion cells
• Pattern: Predictable daily drift of sleep schedule
• Considered orphan disease but common in this population

In Sighted Individuals:

• Rare in sighted people
• Often associated with psychiatric conditions
• May involve avoidance of light exposure
• Social withdrawal and isolation
• More difficult to diagnose and treat

Cyclical Symptoms:

• When aligned: Sleep normal, few symptoms
• When misaligned: Severe insomnia at night, excessive daytime sleepiness
• Cycle duration: Depends on individual's period (e.g., 24.5 hour period cycles every 48 days)
• Alternating symptomatic and asymptomatic periods

Severe Impact:

• Unable to maintain consistent work/school schedule
• Severe social and professional handicap
• Social isolation, psychological difficulties
• Diagnosis often delayed due to cyclical nature

Diagnosis:

• Sleep diary for 2+ weeks showing progressive delay
• Actigraphy demonstrating drift pattern
• Urinary 6-sulfatoxymelatonin measurements
• Confirm circadian period >24.1 hours

5. Irregular Sleep-Wake Rhythm Disorder (ISWRD)

Description:

• Lack of clear circadian sleep-wake pattern
• Sleep fragmented into multiple periods throughout 24 hours
• No single major sleep period
• Multiple naps throughout day and night
• Total sleep time may be relatively normal

Typical Pattern:

• 3 or more sleep episodes per 24 hours
• At least 3 sleep episodes in daytime
• Longest sleep period <4 hours
• Variable, unpredictable timing
• Sleep appears chaotic, disorganized

Common Causes:

• Neurodegeneration: Alzheimer's disease (most common), other dementias
• Brain injury: Traumatic brain injury, stroke affecting SCN
• Developmental disorders: Intellectual disability, autism
• SCN damage: From tumors, neurosurgery
• Lack of environmental time cues (institutionalization)

In Dementia Patients:

• SCN neuronal loss with disease progression
• Reduced light exposure (often indoors)
• Decreased physical activity
• Sundowning (agitation in evening)
• Nighttime wandering
• Major burden for caregivers

Treatment Challenges:

• Difficult to treat due to underlying brain pathology
• Focus on environmental interventions
• Structured daily routines
• Bright light exposure during day
• Melatonin may help some patients

6. Jet Lag Disorder

Description:

• Temporary misalignment after rapid time zone travel
• Internal clock remains on home time initially
• Symptoms during transition to new time zone
• Gradually resolves as clock re-entrains
• Not diagnosed unless causing significant distress

Symptoms:

• Insomnia when trying to sleep at destination bedtime
• Excessive sleepiness during destination daytime
• Poor concentration, reduced alertness
• Fatigue, malaise
• Gastrointestinal upset
• Mood disturbances

Adaptation Rate:

• Approximately 1 day per time zone crossed
• Can take 5-7+ days for complete adjustment
• Individual variation in susceptibility
• Older adults often experience worse symptoms

Directional Differences:

• Eastward travel (phase advance required): More difficult, worse symptoms
• Going to bed earlier than natural tendency
• Example: New York to London (5 hours earlier)
• Westward travel (phase delay required): Easier to adapt
• Going to bed later follows natural tendency
• Example: New York to California (3 hours later)

Prevention Strategies:

• Pre-adjust sleep schedule before departure
• Strategic light exposure on arrival
• Melatonin at destination bedtime
• Stay hydrated, avoid alcohol
• Immediate adoption of destination schedule

Clinical Evaluation

Sleep History:

• Preferred sleep and wake times (when allowed to sleep naturally)
• Work/school schedule requirements
• Sleep quality when occurring at preferred time
• Difficulty falling asleep or waking
• Daytime sleepiness patterns
• Impact on functioning
• Duration of symptoms (chronic vs acute)
• Family history

Questionnaires:

• Morningness-Eveningness Questionnaire (MEQ): Identifies chronotype
• Munich ChronoType Questionnaire: Assesses phase preference
• Pittsburgh Sleep Quality Index (PSQI): Sleep quality assessment
• Epworth Sleepiness Scale (ESS): Daytime sleepiness severity

Rule Out Other Conditions:

• Primary insomnia
• Sleep apnea
• Restless legs syndrome
• Psychiatric disorders (depression, bipolar)
• Medication effects
• Poor sleep hygiene vs true circadian disorder

Sleep Diary

Essential Tool:

• Record for minimum 1-2 weeks (longer better)
• Document every day including weekends
• Can reveal pattern not apparent to patient
• Often diagnostic for DSWPD, ASWPD

Information to Track:

• Bedtime
• Time tried to sleep
• Sleep latency (time to fall asleep)
• Wake time
• Final rise time
• Naps (time and duration)
• Sleep quality rating
• Daytime sleepiness
• Medications, caffeine, alcohol

Patterns Diagnostic For:

• DSWPD: Consistent late sleep-wake times
• ASWPD: Consistent early sleep-wake times
• Non-24: Progressive daily delay (drifting pattern)
• ISWRD: Chaotic, no clear pattern

Actigraphy

Device:

• Wrist-worn accelerometer (like watch)
• Monitors movement to infer sleep-wake patterns
• Worn continuously for 7-14+ days
• Some devices also track light exposure

Advantages:

• Objective measurement
• Long-term monitoring (weeks possible)
• Non-invasive, done at home
• Shows actual behavior vs reported
• Visualizes patterns clearly

What It Shows:

• Sleep-wake timing patterns
• Total sleep time
• Sleep fragmentation
• Nap patterns
• Day-to-day consistency
• Light exposure patterns (if equipped)

Particularly Useful For:

• Confirming DSWPD, ASWPD diagnosis
• Documenting Non-24 drift pattern
• ISWRD fragmentation pattern
• Monitoring treatment response

Dim Light Melatonin Onset (DLMO)

Gold Standard Phase Marker:

• Most reliable measure of circadian phase
• Determines timing of internal clock
• Used in research and specialized clinical settings
• Helps guide treatment timing

Procedure:

• Patient in dim light (<10 lux) for several hours
• Saliva or blood samples collected every 30-60 min
• Typically starts 6 hours before habitual bedtime
• Continues until melatonin levels rise
• DLMO = time when melatonin reaches threshold

Interpretation:

• Normal: DLMO occurs ~2 hours before sleep onset
• DSWPD: DLMO significantly delayed (late night/early morning)
• ASWPD: DLMO significantly advanced (early evening)
• Guides timing of light therapy and melatonin

Limitations:

• Time-consuming, labor-intensive
• Not widely available clinically
• Expensive
• Often diagnosis made without DLMO

Other Assessment Tools

Urinary 6-Sulfatoxymelatonin (aMT6s):

• Major melatonin metabolite in urine
• Collected over multiple days
• Used to determine circadian period (tau)
• Essential for diagnosing Non-24
• Can confirm >24 hour period

Core Body Temperature:

• CBT follows circadian rhythm
• Minimum occurs ~2 hours before natural wake time
• Continuous monitoring possible with sensors
• Research tool, not routine clinical use

Polysomnography (PSG):

• Usually NOT needed for CRSD diagnosis
• Sleep architecture typically normal (when at preferred time)
• May be done to rule out sleep apnea, PLMD
• Multiple Sleep Latency Test (MSLT) can show circadian pattern

Light Therapy Basics

Light Box Specifications:

• Intensity: 2,500-10,000 lux (10,000 lux most effective)
• Spectrum: Broad spectrum white light or blue-enriched (~460nm)
• Distance: Typically 12-24 inches from eyes
• Position: Light should enter eyes at angle (not direct stare)
• UV filtered: Safe for eyes, no UV exposure

Treatment Parameters:

• Duration: 30-120 minutes (longer for lower intensity)
• Frequency: Daily, at same time
• Timing: Critical - depends on disorder and phase response curve
• Eyes open: Must be awake with eyes open
• Can perform other activities (read, eat, computer work)

Blue Light (460-480nm):

• Melanopsin most sensitive to blue wavelengths
• Lower intensity blue light may be as effective
• Shorter exposure duration possible
• More portable devices available
• Still being researched for optimal protocols

Natural Sunlight:

• Very effective (10,000+ lux outdoors even on cloudy day)
• Free and natural
• Timing still critical
• Weather-dependent
• May be impractical for some schedules

Light Therapy for Specific Disorders

Delayed Sleep Phase Disorder (DSWPD):

• Goal: Advance circadian phase earlier
• Timing: Morning light (upon waking or shortly after)
• Protocol: 2,500-10,000 lux for 30-120 min, 6-8 AM
• Critical: Must also avoid bright light in evening
• Dark sunglasses: In evening hours (after ~8 PM)
• Effectiveness: Can advance phase 1-2 hours with consistent use
• Duration: Several weeks to months, then maintenance

Advanced Sleep Phase Disorder (ASWPD):

• Goal: Delay circadian phase later
• Timing: Evening light (2-3 hours before desired bedtime)
• Protocol: 2,500-10,000 lux for 1-2 hours in evening
• Avoid: Bright light in early morning
• Effectiveness: Can delay phase 1-2 hours
• Often less treatment sought (less socially disabling)

Shift Work Disorder:

• Night shift: Bright light during work (especially first half)
• Intermittent exposure: 15-min bursts each hour × 5 hours effective
• Commute home: Dark sunglasses (critical!)
• Daytime sleep: Blackout curtains, dark bedroom
• Goal: Delay phase or maintain partial delay
• Complete circadian reversal difficult and often undesirable

Jet Lag:

• Eastward travel: Morning light on arrival (advance phase)
• Westward travel: Evening light on arrival (delay phase)
• Strategic timing: Based on number of time zones
• Pre-adaptation: Begin shifting before departure
• Natural sunlight very effective

Light Avoidance Strategies

Why Light Avoidance Matters:

• Light at wrong time counteracts treatment
• Evening light delays phase (problematic for DSWPD)
• Morning light advances phase (problematic for ASWPD)
• Light avoidance equally important as light exposure

For DSWPD - Evening Light Restriction:

• Dim lights 2-3 hours before desired bedtime
• Blue light blocking: Amber/orange glasses after sunset
• Screen filters: Enable night mode on devices
• Home lighting: Dim, warm-toned lights in evening
• Target: <200 lux, minimize blue wavelengths

For Shift Workers - Post-Shift Light Avoidance:

• Dark sunglasses: Wear on commute home
• Wraparound style blocks peripheral light
• Critical for maintaining delayed phase
• Without this, morning light shifts phase wrong direction

Sleep Environment:

• Blackout curtains: Essential for shift workers
• Cover all light sources (LEDs, clock displays)
• Eye masks if complete darkness impossible
• Darkness promotes melatonin, consolidates sleep

Safety & Side Effects

Light Therapy Safety:

• Generally very safe when used properly
• UV-filtered light boxes prevent eye/skin damage
• No significant long-term risks identified

Potential Side Effects:

• Eye strain: Mild, usually resolves
• Headache: Reduce intensity or duration
• Nausea: Rare, try shorter sessions
• Agitation/hypomania: Caution in bipolar disorder
• Most side effects mild and transient

Contraindications/Cautions:

• Retinal disease: Consult ophthalmologist first
• Photosensitizing medications: Some antibiotics, NSAIDs, St. John's Wort
• Bipolar disorder: May trigger mania, use cautiously
• Skin conditions: Some light-sensitive skin disorders

Compliance Challenges:

• Requires daily commitment
• Time-consuming (30-120 min)
• Must structure day around light exposure
• Social/professional conflicts possible
• Adherence critical for success

Melatonin

Mechanism:

• Exogenous hormone supplement
• Binds to MT1 and MT2 receptors in SCN
• Phase-shifting effects (timing-dependent)
• Also has mild sleep-promoting effects

Timing Based on Phase Response Curve:

• To advance phase (DSWPD): 5-7 hours before desired bedtime (evening)
• To delay phase (ASWPD): Morning, after waking (rarely used)
• Maximum advance: 3-5 hours before DLMO
• Timing more important than dose

Dosing:

• Low dose: 0.3-0.5 mg (may be more effective for phase shifting)
• Typical dose: 0.5-3 mg
• High dose: 3-10 mg (not necessarily more effective)
• Immediate-release formulation preferred
• Take 30-60 minutes before desired effect

Effectiveness:

• Can advance phase 30-90 minutes
• Less potent than bright light
• Often combined with light therapy for best results
• Most effective for DSWPD, jet lag, shift work

Safety Profile:

• Generally very safe, well-tolerated
• Minimal side effects
• No significant drug interactions
• No tolerance or dependence
• Safe for long-term use

Side Effects (Rare):

• Mild headache
• Dizziness
• Nausea
• Daytime drowsiness (if dose too high or poorly timed)

Limitations:

• Not FDA-approved for CRSDs (available OTC)
• Quality/purity varies between brands
• Lack of standardization
• Effects can be overridden by poorly timed light

Tasimelteon (Hetlioz®)

FDA-Approved for Non-24 in Blind:

• First and only FDA-approved medication for CRSD
• Approved 2014 for Non-24 in totally blind individuals
• Dual MT1/MT2 receptor agonist
• 2-4 times greater affinity for MT2 receptor

Dosing:

• Dose: 20 mg capsule
• Timing: Once daily, 1 hour before target bedtime
• Taken at same time every day
• With or without food

Efficacy in Blind Non-24 Patients:

• 20% achieved entrainment vs 3% placebo (SET trial)
• 24% showed clinical response vs 0% placebo
• 90% maintained entrainment with continued treatment (RESET trial)
• Continued treatment necessary to maintain benefit
• Benefits lost if medication stopped

Side Effects:

• Headache (17% vs 7% placebo)
• Elevated liver enzymes (10% vs 5%)
• Nightmares or abnormal dreams (10% vs 0%)
• Upper respiratory infection (7% vs 0%)
• Urinary tract infection (7% vs 2%)
• Generally well-tolerated

Limitations:

• Very expensive ($15,000+ per year)
• Requires specialty pharmacy
• Only studied in blind population
• Efficacy in sighted Non-24 unknown
• Not approved for other CRSDs

Other Medications

Ramelteon (Rozerem®):

• MT1/MT2 receptor agonist
• FDA-approved for insomnia (not CRSDs)
• 8 mg dose
• Can produce phase shifts (1-1.5 hours)
• Limited evidence for CRSD treatment
• May be helpful but not as well-studied

Modafinil/Armodafinil (for Shift Work Disorder):

• Indication: Excessive sleepiness in SWD
• Mechanism: Wakefulness-promoting agent
• Modafinil: 200 mg 1 hour before shift
• Armodafinil: 150 mg before shift
• Improves alertness during night work
• Does NOT fix circadian misalignment
• Symptomatic treatment only
• Side effects: Headache, nausea, anxiety

Caffeine (for Shift Work):

• Widely used by shift workers
• Improves alertness short-term
• Strategic timing important
• Avoid 4-6 hours before desired sleep
• Can worsen sleep quality if poorly timed
• Risk of tolerance, dependence

Hypnotics (Sleep Medications):

• Generally NOT recommended for CRSDs
• Do not address underlying circadian problem
• May be used short-term for shift workers
• Help daytime sleep in shift workers
• Risk of tolerance, dependence
• Should not be long-term solution

Behavioral Treatments

Chronotherapy (for DSWPD):

• Progressive delay of sleep time by 3 hours every 2 days
• Continue until desired sleep time achieved
• Example: 3 AM → 6 AM → 9 AM → 12 PM → ... → 11 PM
• Takes 1-2 weeks to complete cycle
• Then strict adherence to maintain new schedule
• Limitations: Disruptive, requires time off work/school, high relapse rate
• Largely replaced by light therapy + melatonin

Sleep Hygiene (Essential for All):

• Consistent sleep-wake schedule (even weekends)
• Optimize sleep environment (dark, quiet, cool)
• Avoid alcohol, caffeine before desired sleep
• Regular exercise (but not close to bedtime)
• Avoid screens 1-2 hours before bed

Sleep Anchoring (for Shift Workers):

• Maintain overlapping sleep period on work and off days
• Partial phase delay more sustainable than complete reversal
• Example: Sleep 8 AM-4 PM on work days, 4 AM-12 PM on off days
• Helps stabilize circadian rhythm
• Allows some social engagement on off days

For ISWRD (Dementia Patients):

• Structured daily routine
• Regular meal times
• Daytime bright light exposure (morning preferred)
• Physical and social activities during day
• Minimize daytime napping
• Evening light reduction
• Consistent bedtime routine

Lifestyle Adaptations

Career/Education Considerations:

• Choose schedule-flexible jobs when possible
• Consider remote work opportunities
• Freelance or self-employment may allow natural schedule
• Evening/night shift jobs for DSWPD
• Early morning jobs for ASWPD
• Academic accommodations (later class times, deadline flexibility)

Social Life:

• Educate friends/family about disorder
• Plan social activities at compatible times
• Weekend schedule flexibility when possible
• Find social groups with similar schedules
• Don't feel guilty about biological needs

Long-Term Management:

• CRSDs often chronic, require ongoing treatment
• Maintenance therapy usually needed
• Regular schedule adherence critical
• Weekends/vacations can cause relapse
• Life changes may require treatment adjustment

For Shift Workers

Optimizing Shift Selection:

• Permanent shifts: Better than rotating when possible
• Rotation direction: Request clockwise (day→evening→night)
• Rotation speed: Weekly or longer better than rapid
• Limit consecutive nights: 3-4 maximum
• Forward rotation: Day→Night spans easier than Night→Day

Managing Family Life:

• Communicate sleep needs to family
• Post work/sleep schedule visibly
• Quiet time enforcement during sleep
• Plan quality time on off days
• Partner support crucial

Safety:

• Driving: High risk post-shift, especially morning commute
• Consider nap before driving home
• Caffeine before commute (but not too close to sleep)
• Carpool or public transit when possible
• Pull over if drowsy - never worth the risk

Treatment Adherence

Barriers to Success:

• Time commitment (light therapy, scheduling)
• Social conflicts with treatment schedule
• Difficulty maintaining consistency
• Delayed results (can take weeks)
• Weekend slip-ups

Improving Adherence:

• Integrate light therapy into morning routine (breakfast, news)
• Set daily alarms for melatonin
• Track progress (sleep diary, app)
• Involve family/roommates in plan
• Celebrate small improvements
• Remember: Consistency is key

When to Seek Help:

• Symptoms significantly impact functioning
• Self-treatment not effective after 2-4 weeks
• Depressive symptoms develop
• Need help timing light/melatonin correctly
• Uncertainty about diagnosis
• Consider sleep specialist referral

Sleep Resources

• Stages of Sleep & Dreams
• Narcolepsy
• Insomnia Disorder
• Obstructive Sleep Apnea
• Parasomnias
• Sleep Disorders Overview

Professional Organizations

• American Academy of Sleep Medicine (AASM)
• Society for Research on Biological Rhythms
• National Sleep Foundation
• Circadian Sleep Disorders Network